All Clarivate Analytics websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.
• Teva Pharmaceutical Industries Ltd., of Jerusalem, said it added Lonquex (lipegfilgrastim), a long-acting G-CSF, and Granix (tbo-filgrastim), a short-acting G-CSF, to its oncology biologic portfolio.